BRINP1 and astrocytoma (excluding glioblastoma): Reduced expression of BRINP1 caused by different mechanisms, such as promoter hypermethylation, has been revealed in a number of tumor types including lymphoproliferative malignancies, non-small cell lung carcinomas, and astrocytomas [66–68].